What is the management of Transfusion-Related Acute Lung Injury (TRALI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Transfusion-Related Acute Lung Injury (TRALI)

Immediately stop the transfusion when TRALI is suspected and provide supportive respiratory care—diuretics should be avoided as they are ineffective and potentially harmful. 1, 2

Immediate Actions

When TRALI is suspected (acute respiratory distress, hypoxemia, bilateral pulmonary infiltrates within 6 hours of transfusion):

  • Stop the transfusion immediately and maintain IV access with normal saline 1, 2
  • Monitor vital signs every 5-15 minutes including respiratory rate, pulse, blood pressure, temperature, and oxygen saturation 1, 2
  • In mechanically ventilated patients, monitor peak airway pressure 1
  • Do not administer diuretics—this is a critical pitfall as TRALI involves non-cardiogenic pulmonary edema, not fluid overload, and diuretics are ineffective and may worsen the condition 1, 2

Respiratory Support

The cornerstone of TRALI management is supportive respiratory care:

  • Provide supplemental oxygen to maintain adequate oxygenation 2, 3
  • For severe cases requiring mechanical ventilation, use lung-protective ventilation strategies: avoid high tidal volumes and elevated airway pressures to prevent ventilator-induced lung injury 3
  • Apply positive end-expiratory pressure (PEEP) to prevent low-volume shear stress injury 3
  • Most patients show clinical improvement within the first few hours and resolve completely within 96 hours 4, 5

Fluid Management

  • Maintain appropriate fluid balance without overhydration 1
  • Use conservative fluid practices while avoiding hypotension 3
  • Invasive hemodynamic monitoring may be required in severe cases 5

Pharmacologic Considerations

  • Glucocorticoids are not recommended—the literature is insufficient to support their use in TRALI 3, 5
  • Statins are similarly not supported by current evidence 3

Reporting and Documentation

  • Report all suspected TRALI cases to the local blood bank immediately—TRALI is underdiagnosed and underreported despite being a leading cause of transfusion-associated morbidity and mortality 6, 1, 2
  • Notify the patient's general practitioner to remove them from the donor pool 2
  • Contact the transfusion laboratory to initiate investigation 2

Differential Diagnosis

Distinguish TRALI from Transfusion-Associated Circulatory Overload (TACO):

  • TRALI: Non-cardiogenic pulmonary edema, no cardiovascular changes, no evidence of fluid overload, occurs 1-6 hours post-transfusion 1, 2
  • TACO: Cardiogenic pulmonary edema with cardiovascular changes, evidence of fluid overload, responds to diuretics 2

Prevention Strategies for Future Transfusions

Blood banks have implemented donor screening measures:

  • Screening donors for leukocyte antibodies (HLA class I, II, and granulocyte-specific antibodies) 1, 2
  • Using male-only plasma donors to avoid antibodies from multiparous women 2
  • Fresh frozen plasma and platelet concentrates are the blood products most frequently implicated in TRALI 1, 2, 5

References

Guideline

Management of Transfusion-Related Acute Lung Injury (TRALI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Transfusion-Related Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A suspected case of transfusion-related acute lung injury.

Lung India : official organ of Indian Chest Society, 2011

Research

[Transfusion-related acute lung injury (TRALI)].

Pneumologie (Stuttgart, Germany), 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.